RecruitingEarly Phase 1NCT05700916

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Evaluation of Milk Polar Lipids on Lipoprotein Metabolism, Inflammation, and Gut Microbiota in Dyslipidemic Adults With Abdominal Obesity


Sponsor

University of Connecticut

Enrollment

130 participants

Start Date

Oct 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Dairy Powder and a drug called Milk Polar Lipid-Rich Dairy Powder for people with dyslipidemias and obesity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMilk Polar Lipid-Rich Dairy Powder

Effects of the addition of 6.5 g of milk polar lipids to dairy powder.

DIETARY_SUPPLEMENTDairy Powder

Effects of dairy control powder


Locations(1)

University of Connecticut

Storrs, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05700916


Related Trials